<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34059824</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.</ArticleTitle><Pagination><StartPage>1197</StartPage><EndPage>1204</EndPage><MedlinePgn>1197-1204</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-021-01346-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive, neurodegenerative disease of the lower and upper motor neurons with sporadic or hereditary occurrence. Age of onset, pattern of motor neuron degeneration and disease progression vary widely among individuals with ALS. Various cellular processes may drive ALS pathomechanisms, but a monogenic direct metabolic disturbance has not been causally linked to ALS. Here we show SPTLC1 variants that result in unrestrained sphingoid base synthesis cause a monogenic form of ALS. We identified four specific, dominantly acting SPTLC1 variants in seven families manifesting as childhood-onset ALS. These variants disrupt the normal homeostatic regulation of serine palmitoyltransferase (SPT) by ORMDL proteins, resulting in unregulated SPT activity and elevated levels of canonical SPT products. Notably, this is in contrast with SPTLC1 variants that shift SPT amino acid usage from serine to alanine, result in elevated levels of deoxysphingolipids and manifest with the alternate phenotype of hereditary sensory and autonomic neuropathy. We custom designed small interfering RNAs that selectively target the SPTLC1 ALS allele for degradation, leave the normal allele intact and normalize sphingolipid levels in vitro. The role of primary metabolic disturbances in ALS has been elusive; this study defines excess sphingolipid biosynthesis as a fundamental metabolic mechanism for motor neuron disease.</AbstractText><CopyrightInformation>&#xa9; 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohassel</LastName><ForeName>Payam</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5313-9514</Identifier><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Donkervoort</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lone</LastName><ForeName>Museer A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Nalls</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gable</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9122-1006</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Uniformed Services University of Health Sciences, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gupta</LastName><ForeName>Sita D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0003-2495-1217</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Uniformed Services University of Health Sciences, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foley</LastName><ForeName>A Reghan</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saute</LastName><ForeName>Jonas Alex Morales</ForeName><Initials>JAM</Initials><AffiliationInfo><Affiliation>Medical Genetics division and Neurology division, Hospital de Cl&#xed;nicas de Porto Alegre, Porto Alegre, Brazil; Graduate Program in Medicine: Medical Sciences, and Internal Medicine Department; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Ana Lucila</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Neurology Department, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kok</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurogenetics Outpatient Service, Neurology Department, Hospital das Cl&#xed;nicas da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil and Mendelics, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Introna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3141-6442</Identifier><AffiliationInfo><Affiliation>Neurology Unit, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logroscino</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0423-3242</Identifier><AffiliationInfo><Affiliation>Neurology Unit, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research in Neurology, Center for Neurodegenerative Diseases and the Aging Brain, University of Bari at 'Pia Fondazione Card G. Panico' Hospital Tricase (Le), Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grunseich</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nickolls</LastName><ForeName>Alec R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pourshafie</LastName><ForeName>Naemeh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuhaus</LastName><ForeName>Sarah B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saade</LastName><ForeName>Dimah</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1938-9952</Identifier><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangfu&#xdf;</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9975-0092</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, University Clinic Essen, University of Duisburg-Essen, Duisburg-Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;lbel</LastName><ForeName>Heike</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, University Clinic Essen, University of Duisburg-Essen, Duisburg-Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccus</LastName><ForeName>Zoe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Pichon</LastName><ForeName>Claire E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-9274-3615</Identifier><AffiliationInfo><Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiorillo</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Paediatric Neurology and Muscular Diseases Unit, G. Gaslini Institute and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ly</LastName><ForeName>Cindy V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xf6;pf</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Neuromuscular &amp; Neurometabolic Disorders, Department of Paediatrics, McMaster University, Hamilton Health Sciences Centre, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Specht</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zidell</LastName><ForeName>Aliza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Genetic and Genomic Medicine, Hackensack University Medical Center, Hackensack, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedro</LastName><ForeName>Helio</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Genetic and Genomic Medicine, Hackensack University Medical Center, Hackensack Meridian School of Medicine, Hackensack, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittelmann</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hereditary Neuropathy Foundation Center of Excellence, Neuroscience Institute, Hackensack University Medical Center, Hackensack Meridian School of Medicine, Hackensack, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Florian P</ForeName><Initials>FP</Initials><Identifier Source="ORCID">0000-0002-6103-4138</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hereditary Neuropathy Foundation Center of Excellence, Neuroscience Institute, Hackensack University Medical Center, Hackensack Meridian School of Medicine, Hackensack, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Katherine R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konersman</LastName><ForeName>Chamindra G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Megan T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>GeneDx, Gaithersburg, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandt</LastName><ForeName>Tracy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>GeneDx, Gaithersburg, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straub</LastName><ForeName>Volker</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9046-3540</Identifier><AffiliationInfo><Affiliation>John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>Anne M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Neurology Division, Nationwide Children's Hospital, Ohio State University, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schara</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, University Clinic Essen, University of Duisburg-Essen, Duisburg-Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roos</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, University Clinic Essen, University of Duisburg-Essen, Duisburg-Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarnopolsky</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neuromuscular &amp; Neurometabolic Disorders, Department of Paediatrics, McMaster University, Hamilton Health Sciences Centre, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf6;ke</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1215-3373</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Neuromuscular Division, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chia-Hsueh</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0003-0819-6477</Identifier><AffiliationInfo><Affiliation>Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hornemann</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4218-1087</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunn</LastName><ForeName>Teresa M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0001-9187-8705</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Uniformed Services University of Health Sciences, Bethesda, MD, USA. teresa.dunn-giroux@usuhs.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;nnemann</LastName><ForeName>Carsten G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0002-5930-2324</Identifier><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. carsten.bonnemann@nih.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UM1 HG008900</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS072446</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009141</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 NS107621</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>grant # W81XWH-20-1-0219</GrantID><Agency>United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CDMRP)</Agency><Country/></Grant><Grant><GrantID>R01 GM143282</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 NS10762</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</Agency><Country/></Grant><Grant><GrantID>F32 NS010762</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>grant #31003A_179371</GrantID><Agency>Schweizerischer Nationalfonds zur F&#xf6;rderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013107">Sphingolipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.50</RegistryNumber><NameOfSubstance UI="C487784">SPTLC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.50</RegistryNumber><NameOfSubstance UI="D051102">Serine C-Palmitoyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2021 Jul;17(7):393</RefSource><PMID Version="1">34103709</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005799" MajorTopicYN="N">Genes, Dominant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051102" MajorTopicYN="N">Serine C-Palmitoyltransferase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013107" MajorTopicYN="N">Sphingolipids</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34059824</ArticleId><ArticleId IdType="mid">NIHMS1823668</ArticleId><ArticleId IdType="pmc">PMC9309980</ArticleId><ArticleId IdType="doi">10.1038/s41591-021-01346-1</ArticleId><ArticleId IdType="pii">10.1038/s41591-021-01346-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A &amp; Hardiman O The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol 9, 617&#x2013;628 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B &amp; Robberecht W The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol 10, 661&#x2013;670 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH &amp; Al-Chalabi A Amyotrophic lateral sclerosis. N. Engl. J. Med 377, 162&#x2013;172 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443&#x2013;448 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137, 2329&#x2013;2345 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Breslow DK Sphingolipid homeostasis in the endoplasmic reticulum and beyond. Cold Spring Harb. Perspect. Biol 5, a013326 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3683901</ArticleId><ArticleId IdType="pubmed">23545423</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison PJ, Dunn TM &amp; Campopiano DJ Sphingolipid biosynthesis in man and microbes. Nat. Prod. Rep 35, 921&#x2013;954 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6148460</ArticleId><ArticleId IdType="pubmed">29863195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G &amp; Bieberich E Sphingolipids in neurodegeneration (with focus on ceramide and S1P). Adv. Biol. Regul 70, 51&#x2013;64 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251739</ArticleId><ArticleId IdType="pubmed">30287225</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojjati MR, Li Z &amp; Jiang XC Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. Biochim. Biophys. Acta 1737, 44&#x2013;51 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16216550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L et al. Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration. Proc. Natl Acad. Sci. USA 112, 12962&#x2013;12967 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4620873</ArticleId><ArticleId IdType="pubmed">26438849</ArticleId></ArticleIdList></Reference><Reference><Citation>Bejaoui K et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat. Genet 27, 261&#x2013;262 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11242106</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantner ML et al. Serine and lipid metabolism in macular disease and peripheral neuropathy. N. Engl. J. Med 381, 1422&#x2013;1433 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685488</ArticleId><ArticleId IdType="pubmed">31509666</ArticleId></ArticleIdList></Reference><Reference><Citation>Gable K et al. A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity. J. Biol. Chem 285, 22846&#x2013;22852 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2906276</ArticleId><ArticleId IdType="pubmed">20504773</ArticleId></ArticleIdList></Reference><Reference><Citation>Penno A et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J. Biol. Chem 285, 11178&#x2013;11187 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856995</ArticleId><ArticleId IdType="pubmed">20097765</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M Munsat TL &amp; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord 1, 293&#x2013;299 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434&#x2013;443 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong HY et al. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science 347, 1254806 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362528</ArticleId><ArticleId IdType="pubmed">25525159</ArticleId></ArticleIdList></Reference><Reference><Citation>Han G et al. The topology of the Lcb1p subunit of yeast serine palmitoyltransferase. J. Biol. Chem 279, 53707&#x2013;53716 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15485854</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle MS et al. Transcription factor-mediated differentiation of human iPSCs into neurons. Curr. Protoc. Cell Biol 79, e51 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993937</ArticleId><ArticleId IdType="pubmed">29924488</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman V et al. Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1. Neurology 92, e359&#x2013;e370 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345118</ArticleId><ArticleId IdType="pubmed">30626650</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo K et al. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J. Clin. Invest 121, 4735&#x2013;4745 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3225995</ArticleId><ArticleId IdType="pubmed">22045570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandon EC, van Echten G, Birk R, Schmidt RR &amp; Sandhoff K Sphingolipid biosynthesis in cultured neurons. Down-regulation of serine palmitoyltransferase by sphingoid bases. Eur. J. Biochem 198, 667&#x2013;674 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1646717</ArticleId></ArticleIdList></Reference><Reference><Citation>Siow DL &amp; Wattenberg BW Mammalian ORMDL proteins mediate the feedback response in ceramide biosynthesis. J. Biol. Chem 287, 40198&#x2013;40204 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3504734</ArticleId><ArticleId IdType="pubmed">23066021</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis DL, Gable K, Suemitsu J, Dunn TM &amp; Wattenberg BW The ORMDL/Orm-serine palmitoyltransferase (SPT) complex is directly regulated by ceramide: reconstitution of SPT regulation in isolated membranes. J. Biol. Chem 294, 5146&#x2013;5156 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6442065</ArticleId><ArticleId IdType="pubmed">30700557</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjelmqvist L et al. ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins. Genome Biol 3, RESEARCH0027 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC116724</ArticleId><ArticleId IdType="pubmed">12093374</ArticleId></ArticleIdList></Reference><Reference><Citation>Han G et al. The ORMs interact with transmembrane domain 1 of Lcb1 and regulate serine palmitoyltransferase oligomerization, activity and localization. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864, 245&#x2013;259 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373489</ArticleId><ArticleId IdType="pubmed">30529276</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke BA et al. The Ormdl genes regulate the sphingolipid synthesis pathway to ensure proper myelination and neurologic function in mice. eLife 8, e51067 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6934382</ArticleId><ArticleId IdType="pubmed">31880535</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Xie T, Liu P, Wang L &amp; Gong X Structural insights into the assembly and substrate selectivity of human SPT-ORMDL3 complex. Nat. Struct. Mol. Biol 28, 249&#x2013;257 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33558762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y et al. Structural insights into the regulation of human serine palmitoyltransferase complexes. Nat. Struct. Mol. Biol 28, 240&#x2013;248 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33558761</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackstone C Hereditary spastic paraplegia. Handb. Clin. Neurol 148, 633&#x2013;652 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29478605</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly O et al. A systematic review of genotype phenotype correlation across cohorts having causal mutations of different genes in ALS. J. Pers. Med 10, 58 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7564886</ArticleId><ArticleId IdType="pubmed">32610599</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas G &amp; Veltman JA The role of de novo mutations in adult-onset neurodegenerative disorders. Acta Neuropathol 137, 183&#x2013;207 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6513904</ArticleId><ArticleId IdType="pubmed">30478624</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervenakova L et al. Progressive muscular atrophy variant of familial amyotrophic lateral sclerosis (PMA/ALS). J. Neurol. Sci 177, 124&#x2013;130 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10980308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET &amp; Brown RH Jr. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann. Neurol 43, 703&#x2013;710 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9629839</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer-Grumbach M et al. Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype. Eur. J. Med. Genet 56, 266&#x2013;269 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3682180</ArticleId><ArticleId IdType="pubmed">23454272</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh BC et al. Early-onset severe hereditary sensory and autonomic neuropathy type 1 with S331F SPTLC1 mutation. Mol. Med. Rep 9, 481&#x2013;486 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24247255</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotthier A et al. Genes for hereditary sensory and autonomic neuropathies: a genotype&#x2013;phenotype correlation. Brain 132, 2699&#x2013;2711 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2759337</ArticleId><ArticleId IdType="pubmed">19651702</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode H et al. HSAN1 mutations in serine palmitoyltransferase reveal a close structure&#x2013;function&#x2013;phenotype relationship. Hum. Mol. Genet 25, 853&#x2013;865 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26681808</ArticleId></ArticleIdList></Reference><Reference><Citation>Suriyanarayanan S et al. A novel variant (Asn177Asp) in SPTLC2 causing hereditary sensory autonomic neuropathy type 1C. Neuromolecular Med 21, 182&#x2013;191 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30955194</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmon JM et al. Topological and functional characterization of the ssSPTs, small activating subunits of serine palmitoyltransferase. J. Biol. Chem 288, 10144&#x2013;10153 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617257</ArticleId><ArticleId IdType="pubmed">23426370</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H et al. Lipidomics reveals cerebrospinal-fluid signatures of ALS. Sci. Rep 7, 17652 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5732162</ArticleId><ArticleId IdType="pubmed">29247199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler RG, Pedersen WA, Camandola S, Rothstein JD &amp; Mattson MP Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol 52, 448&#x2013;457 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC et al. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 112, 8100&#x2013;8105 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4491749</ArticleId><ArticleId IdType="pubmed">26056266</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A et al. Sphingolipid metabolism is dysregulated at transcriptomic and metabolic levels in the spinal cord of an animal model of amyotrophic lateral sclerosis. Front. Mol. Neurosci 10, 433 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5758557</ArticleId><ArticleId IdType="pubmed">29354030</ArticleId></ArticleIdList></Reference><Reference><Citation>Alterman JF et al. A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system. Nat. Biotechnol 37, 884&#x2013;894 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6879195</ArticleId><ArticleId IdType="pubmed">31375812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J et al. Patient-customized oligonucleotide therapy for a rare genetic disease. N. Engl. J. Med 381, 1644&#x2013;1652 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961983</ArticleId><ArticleId IdType="pubmed">31597037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacold ME et al. Corrigendum: a PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat. Chem. Biol 12, 656 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27434767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowther J et al. Inhibition of the PLP-dependent enzyme serine palmitoyltransferase by cycloserine: evidence for a novel decarboxylative mechanism of inactivation. Mol. Biosyst 6, 1682&#x2013;1693 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3670083</ArticleId><ArticleId IdType="pubmed">20445930</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho MD &amp; Swash M Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph. Lateral Scler 10, 53&#x2013;57 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>Han G et al. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc. Natl Acad. Sci. USA 106, 8186&#x2013;8191 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2688822</ArticleId><ArticleId IdType="pubmed">19416851</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta SD et al. Expression of the ORMDLS, modulators of serine palmitoyltransferase, is regulated by sphingolipids in mammalian cells. J. Biol. Chem 290, 90&#x2013;98 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281770</ArticleId><ArticleId IdType="pubmed">25395622</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P et al. Dominant collagen XII mutations cause a distal myopathy. Ann. Clin. Transl. Neurol 6, 1980&#x2013;1988 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6801183</ArticleId><ArticleId IdType="pubmed">31509352</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyaoka Y et al. Isolation of single-base genome-edited human iPS cells without antibiotic selection. Nat. Methods 11, 291&#x2013;293 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4063274</ArticleId><ArticleId IdType="pubmed">24509632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone MA et al. Subunit composition of the mammalian serine-palmitoyltransferase defines the spectrum of straight and methyl-branched long-chain bases. Proc. Natl Acad. Sci. USA 117, 15591&#x2013;15598 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7355037</ArticleId><ArticleId IdType="pubmed">32576697</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill AH Jr., Sullards MC, Allegood JC, Kelly S &amp; Wang E Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36, 207&#x2013;224 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15894491</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>